Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$5.69 - $7.17 $929,746 - $1.17 Million
-163,400 Closed
0 $0
Q4 2020

Feb 02, 2021

SELL
$5.65 - $7.66 $104,010 - $141,012
-18,409 Reduced 10.13%
163,400 $1.13 Million
Q3 2020

Nov 05, 2020

BUY
$4.01 - $6.29 $328,443 - $515,188
81,906 Added 81.99%
181,809 $1.03 Million
Q2 2020

Aug 12, 2020

BUY
$3.06 - $6.6 $125,775 - $271,279
41,103 Added 69.9%
99,903 $510,000
Q4 2019

Jan 27, 2020

BUY
$0.93 - $8.58 $14,136 - $130,416
15,200 Added 34.86%
58,800 $505,000
Q2 2019

Aug 15, 2019

BUY
$1.21 - $1.48 $52,756 - $64,528
43,600 New
43,600 $57,000

Others Institutions Holding ISEE

About IVERIC bio, Inc.


  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.